Concepedia

Author

Mireia Segura

Universitat Pompeu Fabra

Also Known As

MIREIA SEGURA, Mireia Segura

12

Publications

1.2K

Citations

12

H-Index

14

Concepts

All Affiliations

Universitat Pompeu FabraMunicipal Institute for Medical ResearchIstituto Superiore di SanitàUniversitat Autònoma de BarcelonaInstituto de Investigaciones Químicas y Ambientales de Barcelona
MS

About

Mireia Segura is an author at Universitat Pompeu Fabra specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

163

2

Biochemistry

3

3

129

3

Natural Sciences

2

2

64

4

Metabolism

1

1

46

5

Neuroscience

1

1

46

Mireia Segura

×

11

Publications

715

Citations

11

H-Index

YearCitations

γ‐Hydroxybutyrate (GHB) in Humans

Sergio Abanades, Mireia Segura, Simona Pichini,

Annals of the New York Academy of Sciences

2006

122

Pharmacological Interaction between 3,4-Methylenedioxymethamphetamine (Ecstasy) and Paroxetine: Pharmacological Effects and Pharmacokinetics

Sergio Abanades, Pere N. Roset, Ana M. Peiró,

Journal of Pharmacology and Experimental Therapeutics

2007

109

3,4-Dihydroxymethamphetamine (HHMA). A Major in Vivo 3,4-methylenedioxymethamphetamine (MDMA) Metabolite in Humans

Mireia Segura, Jordi Ortuño, James A. McLure,

Chemical Research in Toxicology

2001

104

A comparative study on the acute and long‐term effects of MDMA and 3,4‐dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice

Isabel Escobedo, Esther O’Shea, Laura Orío,

British Journal of Pharmacology

2005

68

Contribution ???of ???Cytochrome??? P450??2D6??to??3,4-Methylenedioxymethamphetamine Disposition in Humans

Mireia Segura, Mag Farr, Simona Pichini,

Clinical Pharmacokinetics

2005

65

Disposition of Gamma-Hydroxybutyric Acid in Conventional and Nonconventional Biologic Fluids After Single Drug Administration: Issues in Methodology and Drug Monitoring

Sergio Abanades, Mireia Segura, Simona Pichini,

Therapeutic Drug Monitoring

2007

65

MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers

Rafael de la Torre, Brian Ó. Mathúna, Pere N. Roset,

European Journal of Clinical Pharmacology

2005

52

The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity

Beatriz Goñi‐Allo, Brian Ó. Mathúna, Mireia Segura,

Psychopharmacology

2007

46

Paroxetine Inhibits Acute Effects of 3,4-Methylenedioxymethamphetamine on the Immune System in Humans

Roberta Pacifici, Simona Pichini, Piergiorgio Zuccaro,

Journal of Pharmacology and Experimental Therapeutics

2004

40

Quantitative determination of paroxetine and its 4‐hydroxy‐3‐methoxy metabolite in plasma by high‐performance liquid chromatography/electrospray ion trap mass spectrometry: application to pharmacokinetic studies

Mireia Segura, Jordi Ortuño, Roberta Pacifici,

Rapid Communications in Mass Spectrometry

2003

32

Page 1